Silver Oak Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Silver Oak Securities's BMY Position: Q1 2026 in Review
Silver Oak Securities increased its Bristol-Myers Squibb (BMY) stake by 31% in Q1 2026, buying an estimated $125K and bringing the position to 8,983 shares worth $545K. The position accounts for 0.04% of the portfolio, ranked #407.
Silver Oak Securities first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Silver Oak Securities held 8,983 shares of Bristol-Myers Squibb worth $545K as of Q1 2026.
- Silver Oak Securities bought 2,137 Bristol-Myers Squibb shares in Q1 2026, an estimated $125K.
- Bristol-Myers Squibb made up 0.04% of Silver Oak Securities's portfolio in Q1 2026, its #407 holding.
- Silver Oak Securities first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Silver Oak Securities's 13F filing for Q1 2026, filed 20 Apr 2026.